{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:13:05Z","timestamp":1768867985320,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI22C1424"],"award-info":[{"award-number":["HI22C1424"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2020R1A2C1010293"],"award-info":[{"award-number":["2020R1A2C1010293"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s13770-023-00617-x","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T10:02:10Z","timestamp":1702720930000},"page":"319-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Cetrorelix on Ovary and Endometrium Prior to Anti-PD-L1 Antibody in Murine Model"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7382-230X","authenticated-orcid":false,"given":"Soo Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-519X","authenticated-orcid":false,"given":"Yoon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-821X","authenticated-orcid":false,"given":"Wonhyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9925-8065","authenticated-orcid":false,"given":"Sunwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-3188","authenticated-orcid":false,"given":"Ji Yeon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4689-1323","authenticated-orcid":false,"given":"Sung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5623-6368","authenticated-orcid":false,"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-854X","authenticated-orcid":false,"given":"Seung-Yup","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"617_CR1","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1200\/JCO.19.00934","volume":"37","author":"EB Garon","year":"2019","unstructured":"Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn M-J, et al. Five-year overall survival for patients with advanced non-non-small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study. J Clin Oncol. 2019;37:2518.","journal-title":"J Clin Oncol"},{"key":"617_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","volume":"18","author":"TE Keenan","year":"2020","unstructured":"Keenan TE, Tolaney SM. Role of immunotherapy in triple-negative breast cancer. J Natl Compr Canc Netw. 2020;18:479\u201389.","journal-title":"J Natl Compr Canc Netw"},{"key":"617_CR3","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372:2521\u201332.","journal-title":"N Engl J Med"},{"key":"617_CR4","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","volume":"388","author":"RN Eskander","year":"2023","unstructured":"Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, et al. Pembrolizumab plus chemotherapy in advanced endometrial cancer. N Engl J Med. 2023;388:2159\u201370.","journal-title":"N Engl J Med"},{"key":"617_CR5","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"N Colombo","year":"2021","unstructured":"Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, et al. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med. 2021;385:1856\u201367.","journal-title":"N Engl J Med"},{"key":"617_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/ITT.S284988","volume":"11","author":"AY Lin","year":"2022","unstructured":"Lin AY, Schnitter JM, Gordon LI. Immune checkpoint blockade for the treatment of hodgkin lymphoma. Immunotargets Ther. 2022;11:1\u201310.","journal-title":"Immunotargets Ther"},{"key":"617_CR7","doi-asserted-by":"publisher","first-page":"1157805","DOI":"10.3389\/fendo.2023.1157805","volume":"14","author":"Z Cardona","year":"2023","unstructured":"Cardona Z, Sosman JA, Chandra S, Huang W. Endocrine side effects of immune checkpoint inhibitors. Front Endocrinol (Lausanne). 2023;14:1157805.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"617_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","volume":"184","author":"M Dougan","year":"2021","unstructured":"Dougan M, Luoma AM, Dougan SK, Wucherpfennig KW. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021;184:1575\u201388.","journal-title":"Cell"},{"key":"617_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s43018-022-00422-w","volume":"3","author":"SA Roberts","year":"2022","unstructured":"Roberts SA, Dougan M. Checking ovarian reserves after checkpoint blockade. Nat Cancer. 2022;3:907\u20138.","journal-title":"Nat Cancer"},{"key":"617_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-022-00413-x","volume":"3","author":"AL Winship","year":"2022","unstructured":"Winship AL, Alesi LR, Sant S, Stringer JM, Cantavenera A, Hegarty T, et al. Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice. Nat Cancer. 2022;3:1\u201313.","journal-title":"Nat Cancer"},{"key":"617_CR11","first-page":"281","volume":"7","author":"RK Poga\u010dnik","year":"2014","unstructured":"Poga\u010dnik RK, Vrtovec HM, Vizjak A, Levi\u010dnik AU, Slabe N, Ihan A. Possible role of autoimmunity in patients with premature ovarian insufficiency. Int J Fertility Sterility. 2014;7:281.","journal-title":"Int J Fertility Sterility"},{"key":"617_CR12","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/aji.13622","volume":"88","author":"H Gao","year":"2022","unstructured":"Gao H, Gao L, Wang W. Advances in the cellular immunological pathogenesis and related treatment of primary ovarian insufficiency. Am J Reprod Immunol. 2022;88:e13622.","journal-title":"Am J Reprod Immunol"},{"key":"617_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito S, Nakashima A, Shima T, Ito M. Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601\u201310.","journal-title":"Am J Reprod Immunol"},{"key":"617_CR14","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.3390\/jcm12175585","volume":"12","author":"A-S Braun","year":"2023","unstructured":"Braun A-S, Vomstein K, Reiser E, Tollinger S, Kyvelidou C, Feil K, et al. NK and T cell subtypes in the endometrium of patients with recurrent pregnancy loss and recurrent implantation failure: implications for pregnancy success. J Clin Med. 2023;12:5585.","journal-title":"J Clin Med"},{"key":"617_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-8-51","volume":"8","author":"CN Lemos","year":"2010","unstructured":"Lemos CN, Reis FM, Pena GN, Silveira LC, Camargos AF. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide. Reprod Biol Endocrinol. 2010;8:1\u20137.","journal-title":"Reprod Biol Endocrinol"},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/humrep\/deh257","volume":"19","author":"D Meirow","year":"2004","unstructured":"Meirow D, Assad G, Dor J, Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod. 2004;19:1294\u20139.","journal-title":"Hum Reprod"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/humrep\/deaa349","volume":"36","author":"S Wang","year":"2021","unstructured":"Wang S, Pei L, Hu T, Jia M, Wang S. Protective effect of goserelin on ovarian reserve during (neo) adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China. Hum Reprod. 2021;36:976\u201386.","journal-title":"Hum Reprod"},{"key":"617_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/08923973.2016.1168432","volume":"38","author":"S Wei","year":"2016","unstructured":"Wei S, Guo H, Gong Z, Zhang F, Ma Z. Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice. Immunopharmacol Immunotoxicol. 2016;38:197\u2013204.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"617_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jab.2015.06.003","volume":"14","author":"S Wei","year":"2016","unstructured":"Wei S, Gong Z, An L, Zhang T, Zhang F, Chen S. Cetrorelix and Triptorelin active immunization influences follicle development and receptor expressions of ovaries in mice. J Appl Biomed. 2016;14:49\u201357.","journal-title":"J Appl Biomed"},{"key":"617_CR20","first-page":"117955811986458","volume":"13","author":"F Poggio","year":"2019","unstructured":"Poggio F, Lambertini M, Bighin C, Conte B, Blondeaux E, D\u2019Alonzo A, et al. Potential mechanisms of ovarian protection with gonadotropin-releasing hormone agonist in breast cancer patients: a review. Clin Med Insights: Reproduct Health. 2019;13:1179558119864584.","journal-title":"Clin Med Insights: Reproduct Health"},{"key":"617_CR21","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1210\/en.2006-1265","volume":"148","author":"JA Visser","year":"2007","unstructured":"Visser JA, Durlinger AL, Peters IJ, van den Heuvel ER, Rose UM, Kramer P, et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-M\u00fcllerian hormone null mice. Endocrinology. 2007;148:2301\u20138.","journal-title":"Endocrinology"},{"key":"617_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1095\/biolreprod66.1.77","volume":"66","author":"G Cheng","year":"2002","unstructured":"Cheng G, Weihua Z, M\u00e4kinen S, M\u00e4kel\u00e4 S, Saji S, Warner M, et al. A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod. 2002;66:77\u201384.","journal-title":"Biol Reprod"},{"key":"617_CR23","unstructured":"Suttie AW (2015) Boorman\u2019s pathology of the rat: reference and Atlas. In: Suttie AW, (Eds). Elsevier"},{"key":"617_CR24","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/humrep\/14.7.1903","volume":"14","author":"D Meirow","year":"1999","unstructured":"Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod. 1999;14:1903\u20137.","journal-title":"Hum Reprod"},{"key":"617_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12522-014-0201-5","volume":"14","author":"Y Yamamoto","year":"2015","unstructured":"Yamamoto Y, Kuwahara A, Taniguchi Y, Yamasaki M, Tanaka Y, Mukai Y, et al. Tumor necrosis factor-alpha inhibits ovulation and induces granulosa cell death in rat ovaries. Reprod Med Biol. 2015;14:107\u201315.","journal-title":"Reprod Med Biol"},{"key":"617_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0006-291X(02)00431-X","volume":"294","author":"R Sasson","year":"2002","unstructured":"Sasson R, Winder N, Kees S, Amsterdam A. Induction of apoptosis in granulosa cells by TNF alpha and its attenuation by glucocorticoids involve modulation of Bcl-2. Biochem Biophys Res Commun. 2002;294:51\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"617_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1530\/rep.0.1210843","volume":"121","author":"GW Montgomery","year":"2001","unstructured":"Montgomery GW, Galloway SM, Davis GH, McNatty KP. Genes controlling ovulation rate in sheep. Reproduction-Cambridge-. 2001;121:843\u201352.","journal-title":"Reproduction-Cambridge-"},{"key":"617_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/ijms22010114","volume":"22","author":"L Zakharova","year":"2020","unstructured":"Zakharova L, Sharova V, Izvolskaia M. Mechanisms of reciprocal regulation of gonadotropin-releasing hormone (GnRH)-producing and immune systems: the Role of GnRH, cytokines and their receptors in early ontogenesis in normal and pathological conditions. Int J Mol Sci. 2020;22:114.","journal-title":"Int J Molecular Sci"},{"key":"617_CR29","first-page":"393","volume":"8","author":"L Barbakadze","year":"2015","unstructured":"Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril. 2015;8:393\u20138.","journal-title":"Int J Fertil Steril"},{"key":"617_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/molehr\/gan038","volume":"14","author":"H Matsumoto","year":"2008","unstructured":"Matsumoto H, Sakai K, Iwashita M. Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via alpha5beta1 integrin. Mol Hum Reprod. 2008;14:485\u20139.","journal-title":"Mol Hum Reprod"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1210\/jc.2004-0904","volume":"90","author":"H Okada","year":"2005","unstructured":"Okada H, Nie G, Salamonsen LA. Requirement for proprotein convertase 5\/6 during decidualization of human endometrial stromal cells in vitro. J Clin Endocrinol Metab. 2005;90:1028\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/molehr\/7.4.341","volume":"7","author":"H Okada","year":"2001","unstructured":"Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod. 2001;7:341\u20137.","journal-title":"Mol Hum Reprod"},{"key":"617_CR33","doi-asserted-by":"publisher","first-page":"13382","DOI":"10.3390\/ijms232113382","volume":"23","author":"HM Wu","year":"2022","unstructured":"Wu HM, Chen LH, Hsu LT, Lai CH. Immune tolerance of embryo implantation and pregnancy: the role of human decidual stromal cell- and embryonic-derived extracellular vesicles. Int J Mol Sci. 2022;23:13382.","journal-title":"Int J Mol Sci"},{"key":"617_CR34","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.fertnstert.2007.04.060","volume":"89","author":"BW Rackow","year":"2008","unstructured":"Rackow BW, Kliman HJ, Taylor HS. GnRH antagonists may affect endometrial receptivity. Fertil Steril. 2008;89:1234\u20139.","journal-title":"Fertil Steril"},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/pmic.201400145","volume":"14","author":"Y Meng","year":"2014","unstructured":"Meng Y, Guo Y, Qian Y, Guo X, Gao L, Sha J, et al. Effects of GnRH antagonist on endometrial protein profiles in the window of implantation. Proteomics. 2014;14:2350\u20139.","journal-title":"Proteomics"},{"key":"617_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/aji.12522","volume":"76","author":"N Sung","year":"2016","unstructured":"Sung N, Salazar Garc\u00eda MD, Dambaeva S, Beaman KD, Gilman-Sachs A, Kwak-Kim J. Gonadotropin-releasing hormone analogues lead to pro-inflammatory changes in T lymphocytes. Am J Reprod Immunol. 2016;76:50\u20138.","journal-title":"Am J Reprod Immunol"},{"key":"617_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/humrep\/dey347","volume":"34","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ma L, Hu X, Ji J, Mor G, Liao A. The role of the PD-1\/PD-L1 axis in macrophage differentiation and function during pregnancy. Hum Reprod. 2019;34:25\u201336.","journal-title":"Hum Reprod"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-023-00617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-023-00617-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-023-00617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T16:24:41Z","timestamp":1706545481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-023-00617-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s13770-023-00617-x","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved and conducted in accordance with the guidelines by IACUC of Gyeongsang National University (No. GNU-230425-M0083).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}